Pfizer’s sasanlimab combo significantly improves event-free survival in BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Tuesday, April 29, 2025, 14:00 Hrs [IS ...

underscoring the need for BCG maintenance not only as a component of SOC treatment but also in combination with sasanlimab. Early interim analysis for the key secondary overall survival (OS ...

Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

Balfour Capital Group Appoints Yogi Lamba, Strengthening Global Financial Expertise and Analytical Capabilities Balfour Capital Group (BCG), a leading global investment and financial advisory firm, is ...

Since assuming the CEO role in 2021, Schweizer has driven BCG's growth, expanding BCG's ... Provide specific products and services to you, such as portfolio management or data aggregation.

Emami emerges stronger post-pandemic with rural-led revenue, ayurvedic healthcare focus, and growth potential, making it a ...

McKinsey partner Patricio Ibáñez said shoppers are bracing for costs to rise because of tariffs, and a survey led by the ...

Consumer companies like Unilever and Nestlé constantly jostle over pricing to deliver strong top-line figures without ...